Are maximum P wave duration and P wave dispersion a marker of target organ damage in the hypertensive population?

Clinical Research in Cardiology

Volumn 97, Issue 2, 2008, Pages 98-104

  Dagli, Necati ^a   Karaca, Ilgin ^b   Yavuzkir, Mustafa ^b   Balin, Mehmet ^b   Arslan, Nadi ^b  

^a FIRAT UNIVERSITY   (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

Author keywords

Hypertension; P wave duration; Target organ damage

Indexed keywords

ADULT; ARTICLE; CALCULATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISPERSION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; HEART ATRIUM CONDUCTION; HEART ATRIUM FIBRILLATION; HEART INJURY; HEART LEFT ATRIUM; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE CONDUCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; P WAVE; PATHOPHYSIOLOGY; POPULATION RESEARCH; RISK FACTOR; SEX RATIO; SYSTOLIC BLOOD PRESSURE;

ADULT; BIOLOGICAL MARKERS; BLOOD PRESSURE DETERMINATION; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE, SYSTOLIC; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PROBABILITY; PROGNOSIS; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 39149115088     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-007-0587-8     Document Type: Article

References (31)

1. Gifford RWJ, Kirkendall W, O'Connor DT, Weidman W (1989) Office evaluation of hypertension. A statement for health professionals by a writing group of the Council for High Blood Pressure Research. American Heart Association. Circulation 79:721-731
2. Sharp PS, Chaturvedi N, Wormald R, McKeigue PM, Marmot MG, Young SM (1995) Hypertensive retinopathy in Afro-Caribbeans and Europeans. Prevalence and risk factor relationships. Hypertension 25:1322-1325
3. Aeschbacher BC, Hutter D, Fuhrer J, Weidmann P, Delacretaz E, Allemann Y (2001) Diastolic dysfunction precedes myocardial hypertrophy in the development of hypertension. Am J Hypertens 14:106-113
4. Modena MG, Mattioli AV, Parato VM, Mattioli G (1992) Effectiveness of the antihypertensive action of lisinopril on left ventricular mass and diastolic filling. Eur Heart J 13:1540-1544
5. Cha YM, Redfield MM, Shen WK, Gersh BJ (2004) Atrial fibrillation and ventricular dysfunction: a vicious electromechanical cycle. Circulation 109:2839-2843
6. Lip GY (2001) Regression of left ventricular hypertrophy and improved prognosis: some HOPE now or hype? Circulation 104:1582-1584
7. Schmieder RE, Schrader J, Zidek W, Tebbe U, Paar WD, Bramlage P et al (2007) Low-grade albuminuria and cardiovascular risk: what is the evidence? Clin Res Cardiol 96:247-257
8. Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB (2002) Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 90:1284-1289
9. Tukek T, Akkaya V, Atilgan D, Demirel E, Ozcan M, Guven O et al (2001) Effect of left atrial size and function on P-wave dispersion: a study in patients with paroxysmal atrial fibrillation. Clin Cardiol 24:676-680
10. Aytemir K, Amasyali B, Abali G, Kose S, Kilic A, Onalan O et al (2005) The signal-averaged P-wave duration is longer in hypertensive patients with history of paroxysmal atrial fibrillation as compared to those without. Int J Cardiol 103:37-40
11. Yilmaz R, Demirbag R (2005) P-wave dispersion in patients with stable coronary artery disease and its relationship with severity of the disease. Journal of Electrocardiology 38:279-284
12. Tukek T, Akkaya V, Demirel S, Sozen AB, Kudat H, Atilgan D et al (2000) Effect of Valsalva maneuver on surface electrocardiographic P-wave dispersion in paroxysmal atrial fibrillation. Am J Cardiol 85:896-899
13. ACC/AHA guidelines for the clinical application of echocardiography: executive summary (1997) A report of the American College of Cardiology/ American Heart Association Task Force on practice guidelines (Committee on Clinical Application of Echocardiography). J Am Coll Cardiol 29:862-879
14. European Study Group on Diastolic Heart Failure (1998) How to diagnose diastolic heart failure. Eur Heart J 19: 990-1003
15. Devereux RB, Reichek N (1977) Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55:613-618
16. Chapman N, Mayet J, Ozkor M, Foale R, Thom S, Poulter N (2001) QT intervals and QT dispersion as measures of left ventricular hypertension in an unselected hypertensive population. Am J Hypertens 14:455-462
17. Calhoun DA, Bakir S, Oparil S (2001) Etiology and pathogenesis of essential hypertension. In: Crawford MH, DiMarco JP (eds) Cardiology. Mosby London, pp 3 1.1-3 1.10
18. Brilla CG, Funck RC, Rupp H (2000) Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation 102:1388-1393
19. Mattioli AV, Bonatti S, Monopoli D, Zennaro M, Mattioli G (2005) Left atrial remodelling after short duration atrial fibrillation in hypertrophic hearts. Heart 91:91-92
20. Dilaveris PE, Gialafos EJ, Andrikopoulos GK, Richter DJ, Papanikolaou V, Poralis K et al (2000) Clinical and electrocardiographic predictors of recurrent atrial fibrillation. Pacing Clin Electrophysiol 23:352-358
21. Ozer N, Aytemir K, Ataler E, Sade E, Aksoyek S, Ovunc K et al (2000) P wave dispersion in hypertensive patients with paroxysmal AF. Pacing Clin Electrophysiol 23:1859-1862
22. Senen K, Turhan H, Riza Erbay A, Basar N, Saatci Yasar A, Sahin O et al (2004) P-wave duration and P-wave dispersion in patients with dilated cardiomyopathy. Eur J Heart Fail 6:567-569
23. Turhan H, Yetkin E, Sahin O, Yasar AS, Senen K, Atak R et al (2003) Comparison of P-wave duration and dispersion in patients aged N or=65 years with those aged b or = 45 years. J Electrocardiol 36:321-326
24. Erbay AR, Turhan H, Yasar AS, Bicer A, Senen K, Sasmaz H et al (2005) Effects of long-term beta-blocker therapy on P-wave duration and dispersion in patients with rheumatic mitral stenosis. Int J Cardiol 102:33-37
25. Lammers WJ, Kirchhof C, Bonke FI, Allessie MA (1992) Vulnerability of rabbit atrium to reentry by hypoxia. Role of inhomogeneity in conduction and wavelength. Am J Physiol 262:H47-55
26. Kelm M, Schafer S, Mingers S, Heydthausen M, Vogt M, Motz W et al (1996) Left ventricular mass is linked to cardiac noradrenaline in normotensive and hypertensive patients. J Hypertens 14:1357-1364
27. Cha YM, Dzeja PP, Shen WK, Jahangir A, Hart CY, Terzic A et al (2003) Failing atrial myocardium: energetic deficits accompany structural remodeling and electrical instability. Am J Physiol Heart Circ Physiol 284:H1313-H1320
28. Cheema AN, Ahmed MW, Kadish AH, Goldberger JJ (1995) Effects of autonomic stimulation and blockade on signal-averaged P wave duration. J Am Coll Cardiol 26:497-502
29. Dagli N, Karaca I (2006) Hipertansif olgularda nebivolol tedavisinin P dispersiyonu üzerine etkisi. Firat Medical Journal 11:154-159
30. Vaziri SM, Larson MG, Lauer MS, Benjamin EJ, Levy D (1995) Influence of blood pressure on left atrial size: the Framingham Heart Study. Hypertension 25:1155-1160
31. Lorell BH, Carabello BA (2000) Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation 102:470-479